Publication | Closed Access

ESX-5-targeted export of ESAT-6 in BCG combines enhanced immunogenicity & efficacy against murine tuberculosis with low virulence and reduced persistence

Clinical ImmunologyBcg CombinesPulmonary TuberculosisImmune RegulationImmunologyTuberculosisHumoral ImmunityEsx-5-targeted ExportImmunotherapyMedicineMurine Tuberculosis